Refenesen Mucus Relief Tablet
Product Images NDC 10956-845

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Refenesen Mucus Relief (NDC 10956-845). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Reese Pharmaceutical Co, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Carton Label (Carton)

Refenesen is an expectorant that contains Guaifenesin at a dose of 400mg in each caplet. It helps to loosen phlegm and thin bronchial secretions making coughs more productive to clear the air passageways. Refenesen comes in a pack of 30 caplets which should be taken every 4 hours as needed, and a maximum of 6 caplets should be consumed in 24 hours. The usage of Refenesen is not suitable for children under 6 years old, and for those who suffer from chronic coughs, smoking-related diseases such as asthma or bronchitis, or emphysema. In case of an overdose or any severe symptoms, it is essential to seek medical assistance immediately.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.